MedTrace Logo

Anti-nucleosome B Lymphocytes in Lupus

NCT01889654 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2017-09-11

No results posted yet for this study

Summary

Lupus disease is characterized by the production of pathogenic autoantibodies, which participate in end-organ damages. The phenotype of B cells producing the pathogenic autoantibodies in lupus patients is today unknown. Antinucleosome antibodies are characteristic of lupus disease.This project proposes to detect antinucleosome B cells in lupus patients and to analyse their phenotype and their frequency.

Conditions

  • Systemic Lupus Erythematosus With or Without Clinical Activity

Interventions

OTHER

Venous blood sampling

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01889654 on ClinicalTrials.gov